Cite
Collaborative Development of 2-Hydroxypropyl-β-Cyclodextrin for the Treatment of Niemann-Pick Type C1 Disease
MLA
Ottinger, Elizabeth A., et al. Collaborative Development of 2-Hydroxypropyl-β-Cyclodextrin for the Treatment of Niemann-Pick Type C1 Disease. Jan. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........bf13b371dc8ced7cbf251a53537fb903&authtype=sso&custid=ns315887.
APA
Ottinger, E. A., Kao, M. L., Carrillo-Carrasco, N., Yanjanin, N., Shankar, R. K., Janssen, M., Brewster, M., Scott, I., Xu, X., Cradock, J., Terse, P., Dehdashti, S., Marugan, J., Zheng, W., Portilla, L., Hubbs, A., Pavan, W. J., Heiss, J., Vite, C. H., … McKew, J. C. (2014). Collaborative Development of 2-Hydroxypropyl-β-Cyclodextrin for the Treatment of Niemann-Pick Type C1 Disease.
Chicago
Ottinger, Elizabeth A., Mark L. Kao, Nuria Carrillo-Carrasco, Nicole Yanjanin, Roopa Kanakatti Shankar, Marjo Janssen, Marcus Brewster, et al. 2014. “Collaborative Development of 2-Hydroxypropyl-β-Cyclodextrin for the Treatment of Niemann-Pick Type C1 Disease,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........bf13b371dc8ced7cbf251a53537fb903&authtype=sso&custid=ns315887.